TrialX
Image

Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID

Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID

Recruiting
100 years and younger
All
Phase N/A

Overview

Maternal-fetal transmission in the second or third trimester of pregnancy of the SARS-COV-2 virus could explain some late fetal losses.

Finding a cause in the context of fetal loss is essential for parents and caregivers. It helps to understand the history of the disease, to address the possible risk of a recurrence and to plan for future pregnancies.

If the maternal-fetal transmission of COVID 19 is confirmed and that it is responsible for obstetric complications, a preventive action could be proposed to the patients by the preconception vaccination.

The investigators are seeking to clarify the frequency of this transmission is information awaited by caregivers, women, couples in particular when the latter are in distress from late fetal loss.

Eligibility

Inclusion Criteria:

  • Major patient
  • Patient with late spontaneous abortion (15 weeks of gestation)
  • Benefiting from a Social Security scheme
  • Patient who consented to participate in the study
  • Free subject, without tutorship, curatorship or subordination

Exclusion Criteria:

  • Persons not benefiting from a Social Security scheme or not benefiting from it through a third party.
  • Concurrent participation in another clinical research study.

Study details
    Identification of the Mother or Fetus Contamination by SARS Cov-2
    Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father
    The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes
    Analysis Laboratories of the Poitiers CHU

NCT04387253

Poitiers University Hospital

5 August 2020

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.